Patent application number | Description | Published |
20090000717 | Steel Cord, Rubber-Steel Cord Composite and Tire - A steel cord that is especially useful for reinforcing a crown portion of a tire is provided. In particular, a steel cord free from manufacturing problems existed in the conventional art and allowing for stable quality and good production efficiency is provided, and a rubber-steel cord composite and a tire that are equipped with the same are provided. | 01-01-2009 |
20100000645 | STEEL CORD, COMPOSITE OF RUBBER AND STEEL CORD, AND TIRE - A steel cord which has no production problem noted in the related art and which can be produced efficiently with stable quality, particularly a steel cord useful for the purpose of reinforcing a tire crown portion, as well as a composite of rubber and steel cord and a tire, which include the steel cord, are provided. | 01-07-2010 |
20100218872 | RUBBER-STEEL CORD COMPOSITE AND TIRE USING THE SAME - A rubber-steel cord composite is provided having nonlinear physical properties even in a rubber characterized by incompressive properties after vulcanization, and hence the rubber-steel cord composite can show low rigidity and flexible properties in a low-strain region and, on the other hand, can show high rigidity in a high-strain region. The rubber-steel cord composite is provided by bundling steel linear objects | 09-02-2010 |
20120073721 | RUBBER-STEEL CORD COMPOSITE AND TIRE USING THE SAME - A rubber-steel cord composite is provided having nonlinear physical properties even in a rubber characterized by incompressive properties after vulcanization, and hence the rubber-steel cord composite can show low rigidity and flexible properties in a low-strain region and, on the other hand, can show high rigidity in a high-strain region. The rubber-steel cord composite is provided by bundling steel linear objects | 03-29-2012 |
Patent application number | Description | Published |
20140093254 | VISIBLE LIGHT RECEIVING DEVICE AND VISIBLE LIGHT RECEIVING METHOD - A receiving device includes a first conversion unit, an amplification unit, and a microcomputer. The microcomputer includes: a second conversion unit that performs, for each sampling time duration, AD conversion on a voltage signal into an AD-converted value; a first calculation unit that calculates a difference digital value by difference calculation; a second calculation unit that calculates a positive reference value and a negative reference value; a detection unit that detects a rising point starting difference digital values greater than the positive reference value, and a falling point starting difference digital values smaller than the negative reference value; a third calculation unit that calculates a first sample period and a second sample period; and a fourth calculation unit that calculates a modulated signal for each symbol time period based on the first sample period and the second sample period. | 04-03-2014 |
20140207490 | AUTHENTICATION SYSTEM IN FACILITY - A first luminaire | 07-24-2014 |
20150098708 | VISIBLE LIGHT COMMUNICATION APPARATUS - A visible light communication apparatus includes a constant current circuit and a load circuit including light emitting elements connected to output terminals of the constant current circuit. Further, the visible light communication apparatus includes a load variation circuit configured to change load characteristics of the load circuit by electrically connecting to the load circuit, the load variation circuit including a series circuit of a diode and a resistor connected in series to the load circuit and a switching element configured to electrically connect or disconnect the load variation circuit to the load circuit in response to a binary communication signal. | 04-09-2015 |
20150229392 | OPTICAL SIGNAL RECEIVER, OPTICAL SIGNAL COMMUNICATION SYSTEM AND OPTICAL SIGNAL RECEIVING METHOD - An optical signal receiver receives an optical signal superimposed on illumination light from an illumination apparatus which repetitively transmits as the optical signal a frame including predetermined information and a preamble indicating the start of the frame. Further, the optical signal receiver includes a light receiving unit configured to receive the optical signal, and a controller configured to control the light receiving unit based on the optical signal received by the light receiving unit such that the optical signal receiver operates in either one of an intermittent reception mode of intermittently receiving the optical signal and a continuous reception mode of continuously receiving the optical signal. | 08-13-2015 |
20150263808 | ILLUMINATION LIGHT COMMUNICATION APPARATUS AND ILLUMINATION LIGHT COMMUNICATION SYSTEM USING THE SAME - An illumination light communication apparatus includes: a light source; a power supply circuit; a switching element which modulates an output current supplied from the power supply circuit to the light source; a visible light communication signal circuit which controls ON and OFF of the switching element to output a modulating signal for superimposing a visible light beacon signal including a unique ID onto the illumination light emitted from the light source; a control power supply circuit which supplies power to the visible light communication signal circuit; a wireless module which transmits a radio wave beacon signal including a unique ID; and a radio wave beacon controlling and transmitting circuit which controls the radio wave beacon signal transmitted from the wireless module, wherein the radio wave beacon controlling and transmitting circuit is supplied with power from the control power supply circuit. | 09-17-2015 |
20150365173 | WORKER MANAGEMENT DEVICE, WORKER MANAGEMENT SYSTEM, AND WORKWEAR - A worker management device that manages a worker wearing workwear includes: a main body; a light receiver that is provided on a part of the main body that is exposed when the main body is attached to the workwear, and receives light including predetermined identification information; a controller connected to the light receiver; and a communication unit connected to the controller. | 12-17-2015 |
Patent application number | Description | Published |
20090004170 | COMPOSITION COMPRISING COENZYME Q10 - The present invention provides a composition superior in water-dispersibility/solubility, workability and tabletability, which contains coenzyme Q10, casein, and a saccharide other than polysaccharides, at a particular ratio. The composition can be utilized for food, food with nutrient function claims, food for specified health uses, nutritional supplement, nutritional product, animal drug, drinks, feed, pharmaceutical product, quasi-drug, cosmetic and the like. | 01-01-2009 |
20090004304 | COMPOSITION COMPRISING BIOACTIVE SUBSTANCE - The present invention provides a powder superior in water-dispersibility/solubility, workability and tabletability, which contains an oil component containing a bioactive substance, a water-soluble polymer, a saccharide other than polysaccharides and a surfactant, at a particular ratio. The powder can be utilized for food, food with nutrient function claims, food for specified health uses, nutritional supplement, nutritional product, animal drug, drinks, feed, pharmaceutical product, quasi-drug, cosmetic and the like. | 01-01-2009 |
Patent application number | Description | Published |
20090041876 | OIL/FAT-CONTAINING COMPOSITION FOR SUPPRESSION OF CARCINOGENESIS - The present invention relates to an oil/fat-containing composition for suppressing carcinogenesis, the composition including a solution produced by bringing a hydrophobic extract of licorice, which has been produced by bringing licorice into contact with an alcohol, into contact with an oil/fat. According to the present invention, there are provided an oil/fat-containing composition for prevention or treatment of the cancer, which can act through oral administration, and can be safely ingested on a day-to-day basis, pharmaceuticals and foods containing the oil/fat-containing composition. | 02-12-2009 |
20090087419 | LICORICE POLYPHENOL PREPARATION - This invention provides a highly concentrated licorice polyphenol preparation with high bioavailability. Further, this invention is intended to maintain high transparency of a composition without deterioration of the indigenous properties of an aqueous substance, even when such composition is added thereto. Such licorice polyphenol preparation comprises a hydrophobic licorice extract comprising licorice polyphenol as a primary component, medium-chain fatty acid triglyceride, and polyoxyethylene sorbitan fatty acid ester, and the ratio of the total weight of the hydrophobic licorice extract and medium-chain fatty acid triglyceride to the weight of polyoxyethylene sorbitan fatty acid ester is between 1:1 and 1:10. | 04-02-2009 |
20090098097 | COMPOSITION FOR NORMALIZING BLOOD PRESSURE - The present invention aims to provide a composition suitable for normalizing the blood pressure, which is useful as food, health food, supplement, nutritional supplement, food for specified health uses, food with nutrient function claims, pharmaceutical product, quasi-drug, feed or pet food. | 04-16-2009 |
20090142324 | OIL-IN-WATER TYPE EMULSION CONTAINING COENZYME Q10 AND PROCESS FOR PRODUCING THE SAME - To provide an oil-in-water emulsion composition that prevents separation of coenzyme Q | 06-04-2009 |
20090208472 | OIL-IN-WATER EMULSION COMPOSITION CONTAINING LICORICE-DERIVED POLYPHENOL - The present invention provides a licorice polyphenol-containing oil-in-water emulsion composition comprising medium-chain triglyceride, a licorice hydrophobic extract comprising, as a main component, licorice polyphenol in a weight ratio relative to the medium-chain triglyceride of 1-50%, and a polyglycerol fatty acid ester comprised of a fatty acid residue having a carbon number of not less than 14. Since the composition of the present invention is superior in transparency, stable to acid and heat, soluble in water, it can be used for food, drink, pharmaceutical product, quasi-drug, cosmetic and the like, which enables efficient supply of a licorice hydrophobic extract such as licorice polyphenol and the like. | 08-20-2009 |
20100284983 | COENZYME Q10-CONTAINING WATER-SOLUBLE COMPOSITION AND PROCESS FOR PRODUCTION THEREOF - A coenzyme Q | 11-11-2010 |
20130309338 | BIOLOGICALLY ACTIVE SUBSTANCE-CONTAINING WATER-SOLUBILIZING PREPARATION AND METHOD FOR PRODUCING THE SAME - An object of the present invention is to provide a water-solubilizing preparation that is obtained by convenient steps without use of a special apparatus such as a high-pressure homogenizer, does not impair the original properties of a water-based material even after being added to the material, has high dispersibility and transparency and excellent heat resistance and acid resistance, and can maintain stability. The water-solubilizing preparation of the present invention is a biologically active substance-containing water-solubilizing preparation comprising 1 to 50% by weight of an oily ingredient (A) containing a biologically active substance and oil, 10 to 98% by weight of a polyglycerin fatty acid ester (B) having an HLB value of 12.5 or larger, and 1 to 40% by weight of a surfactant (C) having an HLB value of 7 to 11.8. | 11-21-2013 |
Patent application number | Description | Published |
20090238863 | LIPOSOME COMPOSITION FOR INDUCTION OF IMMUNITY - It is an object of the present invention to provide a liposome composition which is able to allow the MHC class I and class II molecules of antigen-presenting cells to efficiently present an antigen substance. The present invention provides a liposome composition, which comprises an oligosaccharide-coated liposome and an antigen substance and is used to cause the MHC class I and class II molecules of an antigen-presenting cell to present an antigen peptide. | 09-24-2009 |
20120065089 | Method For Detecting And Distinguishing Intrahepatic Cholangiocarcinoma - Disclosed are a method for early, sensitively and reliably detecting and distinguishing intrahepatic cholangiocarcinoma in a malignant tumor occurring primarily in the liver in a simple way, and a kit therefor. In the method, a glycan biomarker consisting of a lectin WFA (Wisteria floribunda Agglutinin)-binding glycoprotein derived from intrahepatic cholangiocarcinoma is used as a cancer marker to detect intrahepatic cholangiocarcinoma by detecting the cancer marker in a test specimen. The method for detecting intrahepatic cholangiocarcinoma can clearly differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma and enables early detection and determination with a performance clinically acceptable in terms of applicability, sensitivity and precision. | 03-15-2012 |
20120172247 | Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease - An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Disclosed is a method for measuring at least one glycoprotein selected from alpha-1-acid glycoprotein (AGP) and Mac-2-binding protein (M2BP) contained in a sample collected from a subject, comprising: measuring AGP binding to a first lectin selected from AOL and MAL, when the glycoprotein is AGP; and measuring M2BP binding to a second lectin selected from WFA, BPL, AAL, RCA120, and TJAII, when the glycoprotein is M2BP. | 07-05-2012 |
20120190576 | Glycan Markers as Measure of Disease State of Hepatic Diseases - The present invention is directed to developing a glycan markers capable of detecting a hepatic disease, and more specifically to developing a glycan marker indicating a hepatic disease-state. Furthermore, the present invention is also directed to developing a glycan marker capable of distinguishing hepatic disease-states with the progress of hepatocarcinoma. The present inventors identified, among the serum glycoproteins, glycopeptides and glycoproteins in which a glycan structure specifically changes due to a hepatic diseases including hepatocarcinoma and provide these as novel glycan markers (glycopeptide and glycoprotein) specific to hepatic disease-states. | 07-26-2012 |
20130288272 | LUNG CANCER DIFFERENTIAL MARKER - An object of the present invention is to develop and provide a lung cancer differential marker with which lung cancer can be diagnosed conveniently and highly sensitively without depending only on increase or decrease in protein expression level between cancer patients and healthy persons. Another object of the present invention is to develop and provide a glycan marker capable of distinguishing histological types of lung cancer. Of serum glycoproteins, glycopeptide and glycoprotein groups whose glycan structures were altered specifically in lung cancer cell culture supernatants were identified, and they are provided as lung cancer differential markers. | 10-31-2013 |
20140057286 | Method for Measuring Glycoprotein, Method for Examining Liver Desease, Reagent for Quantitative Determination of Glycoprotein and Glycan-Marker Glycoprotein as an Index for Clinical Conditions of Liver Disease - An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a reagent for quantitative determination of a glycoprotein, which is used for the above measurement methods. Furthermore, an object of the present invention is to provide a glycan-marker glycoprotein as an index for clinical conditions of liver disease, which is capable of identifying the clinical conditions of liver disease depending on the progress of liver disease. The method for measuring a glycoprotein is characterized in that: the glycoprotein is at least one glycoprotein selected from alpha-1-acid glycoprotein (AGP) and Mac-2-binding protein (M2BP) contained in a sample collected from a subject; when the glycoprotein is AGP, AGP binding to a first lectin selected from AOL and MAL is measured; and when the glycoprotein is M2BP, M2BP binding to a second lectin selected from WFA, BPL, AAL, RCA120, and TJAII is measured. | 02-27-2014 |
20140242607 | ANTIBODY FOR DETECTING EPITHELIAL OVARIAN CANCER MARKER AND METHOD FOR DIAGNOSING EPITHELIAL OVARIAN CANCER - It is intended to find a highly specific epithelial ovarian cancer marker and to provide an antibody capable of specifically recognizing and detecting the marker or a fragment of the antibody. The present invention provides an anti-β1,6-N-acetylglucosaminyltransferase 5B antibody for diagnosis of epithelial ovarian cancer, i.e., an antibody for detection of a glycosyltransferase β1,6-N-acetylglucosaminyltransferase 5B as an epithelial ovarian cancer marker. The antibody recognizes, as an epitope, a part of a polypeptide of the enzyme consisting of the amino acid sequence represented by SEQ ID NO: 1. | 08-28-2014 |
20140295455 | ANTIBODY FOR DETECTING EPITHELIAL OVARIAN CANCER MARKER AND METHOD FOR DIAGNOSING EPITHELIAL OVARIAN CANCER - The present invention provides an antibody capable of specifically recognizing and detecting the highly specific cancer marker with respect to the epithelial ovarian cancer, or a fragment of the antibody. The present invention provides an anti-β1,3-N-acetylglucosaminyltransferase 3 antibody for diagnosis of epithelial ovarian cancer, i.e., an antibody for detection of a glycosyltransferase β1,3-N-acetylglucosaminyltransferase 3 as an epithelial ovarian cancer marker. The antibody recognizes, as an epitope, a part of a polypeptide of the enzyme consisting of the amino acid sequence represented by SEQ ID NO: 1. | 10-02-2014 |
20140312241 | PLASMA EVALUATION APPARATUS - [Problem] To provide a system and a method for objectively evaluating plasma by easily measuring a current generated by a plasma treatment equipment for medical purposes, etc., and a current flowing through a living body, etc. | 10-23-2014 |
20150293104 | EPITHELIAL OVARIAN CANCER DIFFERENTIATION MARKER - An object of the present invention is to develop and provide an epithelial ovarian cancer diagnosis marker with which epithelial ovarian cancer can be detected inexpensively, conveniently, and low invasively with high accuracy, and a method for determining the presence or absence of epithelial ovarian cancer using the marker. The present invention provides a glycoprotein having a glycan-linked asparagine residue at a particular site of the glycoprotein secreted from an epithelial ovarian cancer cell, or a fragment thereof having the glycan as an epithelial ovarian cancer diagnosis marker. The present invention also provides a method for determining the presence or absence of epithelial ovarian cancer using the glycoprotein. | 10-15-2015 |